Concepts (106)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Atrial Fibrillation | 10 | 2022 | 4531 | 1.240 |
Why?
|
| Catheter Ablation | 8 | 2022 | 2563 | 1.120 |
Why?
|
| Sleep Apnea, Central | 1 | 2017 | 81 | 0.600 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2022 | 886 | 0.530 |
Why?
|
| Continuous Positive Airway Pressure | 2 | 2022 | 549 | 0.530 |
Why?
|
| Electric Countershock | 2 | 2019 | 515 | 0.520 |
Why?
|
| Sleep Apnea, Obstructive | 2 | 2017 | 1726 | 0.480 |
Why?
|
| Vascular System Injuries | 1 | 2013 | 216 | 0.380 |
Why?
|
| Pulmonary Veins | 1 | 2013 | 717 | 0.320 |
Why?
|
| Cardiac Resynchronization Therapy | 1 | 2013 | 501 | 0.310 |
Why?
|
| Aortic Diseases | 1 | 2013 | 726 | 0.310 |
Why?
|
| Pravastatin | 1 | 2009 | 392 | 0.310 |
Why?
|
| Heptanoic Acids | 1 | 2009 | 353 | 0.310 |
Why?
|
| Primary Prevention | 1 | 2013 | 1152 | 0.270 |
Why?
|
| Aorta | 1 | 2013 | 2114 | 0.260 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2013 | 1503 | 0.260 |
Why?
|
| Bed Rest | 1 | 2022 | 82 | 0.220 |
Why?
|
| Anti-Arrhythmia Agents | 3 | 2022 | 766 | 0.220 |
Why?
|
| Acute Coronary Syndrome | 3 | 2012 | 2262 | 0.220 |
Why?
|
| Pyrroles | 1 | 2009 | 1188 | 0.220 |
Why?
|
| Atrioventricular Block | 1 | 2022 | 111 | 0.200 |
Why?
|
| Amiodarone | 1 | 2021 | 203 | 0.190 |
Why?
|
| Pacemaker, Artificial | 1 | 2022 | 768 | 0.150 |
Why?
|
| Tachycardia, Supraventricular | 1 | 2016 | 237 | 0.130 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2009 | 3130 | 0.130 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2016 | 470 | 0.120 |
Why?
|
| Thromboembolism | 1 | 2019 | 986 | 0.120 |
Why?
|
| Feasibility Studies | 1 | 2022 | 4921 | 0.110 |
Why?
|
| Hemorrhage | 2 | 2022 | 3276 | 0.110 |
Why?
|
| Cardiac Resynchronization Therapy Devices | 1 | 2013 | 123 | 0.110 |
Why?
|
| Hirudins | 1 | 2012 | 176 | 0.100 |
Why?
|
| Cicatrix | 1 | 2016 | 694 | 0.100 |
Why?
|
| Treatment Outcome | 9 | 2022 | 62348 | 0.100 |
Why?
|
| Postoperative Complications | 1 | 2013 | 15126 | 0.100 |
Why?
|
| Aortic Valve Stenosis | 1 | 2022 | 1855 | 0.090 |
Why?
|
| Patient Discharge | 1 | 2022 | 3031 | 0.090 |
Why?
|
| Antithrombins | 1 | 2012 | 297 | 0.090 |
Why?
|
| Angioplasty | 1 | 2012 | 405 | 0.090 |
Why?
|
| Radionuclide Imaging | 1 | 2013 | 2037 | 0.090 |
Why?
|
| Gadolinium | 1 | 2013 | 910 | 0.080 |
Why?
|
| Heart Atria | 1 | 2013 | 1273 | 0.080 |
Why?
|
| Analgesics, Opioid | 1 | 2022 | 3385 | 0.070 |
Why?
|
| Thiophenes | 1 | 2010 | 603 | 0.070 |
Why?
|
| Angina, Unstable | 1 | 2010 | 930 | 0.070 |
Why?
|
| Humans | 16 | 2022 | 717237 | 0.070 |
Why?
|
| Healthcare Disparities | 1 | 2020 | 3031 | 0.070 |
Why?
|
| Coronary Stenosis | 1 | 2010 | 810 | 0.060 |
Why?
|
| Retrospective Studies | 5 | 2022 | 72614 | 0.060 |
Why?
|
| Risk Factors | 5 | 2022 | 70864 | 0.060 |
Why?
|
| Middle Aged | 10 | 2022 | 215041 | 0.060 |
Why?
|
| Defibrillators, Implantable | 1 | 2013 | 1407 | 0.060 |
Why?
|
| Cost-Benefit Analysis | 2 | 2013 | 5268 | 0.060 |
Why?
|
| Seasons | 1 | 2009 | 1431 | 0.060 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2010 | 1864 | 0.060 |
Why?
|
| Male | 11 | 2022 | 351380 | 0.060 |
Why?
|
| Cholesterol, HDL | 1 | 2009 | 1840 | 0.050 |
Why?
|
| Image Enhancement | 1 | 2013 | 2979 | 0.050 |
Why?
|
| Sotalol | 1 | 2021 | 45 | 0.050 |
Why?
|
| Adult | 7 | 2022 | 212451 | 0.050 |
Why?
|
| Flecainide | 1 | 2021 | 32 | 0.050 |
Why?
|
| Female | 10 | 2022 | 377909 | 0.050 |
Why?
|
| Age Factors | 2 | 2020 | 18798 | 0.050 |
Why?
|
| Myocardial Infarction | 2 | 2012 | 11423 | 0.050 |
Why?
|
| Piperazines | 1 | 2010 | 2543 | 0.050 |
Why?
|
| Health Care Costs | 1 | 2013 | 3179 | 0.050 |
Why?
|
| Cholesterol, LDL | 1 | 2009 | 2372 | 0.040 |
Why?
|
| Aged | 6 | 2022 | 162856 | 0.040 |
Why?
|
| Peptide Fragments | 1 | 2012 | 5160 | 0.040 |
Why?
|
| Medication Therapy Management | 1 | 2019 | 129 | 0.040 |
Why?
|
| Coronary Angiography | 1 | 2010 | 4419 | 0.040 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2022 | 846 | 0.040 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2010 | 3009 | 0.040 |
Why?
|
| Prognosis | 1 | 2017 | 29226 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2017 | 51275 | 0.040 |
Why?
|
| Aged, 80 and over | 3 | 2022 | 58528 | 0.030 |
Why?
|
| Electrocardiography | 3 | 2012 | 6409 | 0.030 |
Why?
|
| Needs Assessment | 1 | 2019 | 1151 | 0.030 |
Why?
|
| Young Adult | 4 | 2022 | 56247 | 0.030 |
Why?
|
| Intraoperative Care | 1 | 2016 | 785 | 0.030 |
Why?
|
| Aortic Valve | 1 | 2022 | 1835 | 0.030 |
Why?
|
| Heart Conduction System | 1 | 2016 | 1032 | 0.020 |
Why?
|
| Residence Characteristics | 1 | 2020 | 1982 | 0.020 |
Why?
|
| Creatine Kinase, MB Form | 1 | 2010 | 221 | 0.020 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2012 | 648 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2022 | 3473 | 0.020 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2022 | 2936 | 0.020 |
Why?
|
| Vascular Patency | 1 | 2010 | 907 | 0.020 |
Why?
|
| Adolescent | 3 | 2022 | 85139 | 0.020 |
Why?
|
| Drug Resistance | 1 | 2012 | 1613 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2013 | 34502 | 0.020 |
Why?
|
| Comorbidity | 1 | 2020 | 10451 | 0.020 |
Why?
|
| Heparin | 1 | 2012 | 1637 | 0.020 |
Why?
|
| Time Factors | 2 | 2020 | 41095 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 3565 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2012 | 6860 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2010 | 4356 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2012 | 6778 | 0.010 |
Why?
|
| Coronary Vessels | 1 | 2012 | 2988 | 0.010 |
Why?
|
| Recurrence | 1 | 2012 | 8282 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2012 | 10542 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2012 | 12483 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2010 | 12417 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2010 | 9577 | 0.010 |
Why?
|
| United States | 1 | 2020 | 67798 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2012 | 39302 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2010 | 23542 | 0.010 |
Why?
|
Concepts
(106)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(28)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_